Alessandro Muzzi

Alessandro Muzzi

GlaxoSmithKline - Needham / United Kingdom
Natural Sciences / Biological Science
AD Scientific Index ID: 4370275
-
person_outline Alessandro Muzzi's MOST POPULAR ARTICLES
1-) Molecular and cellular signatures of human vaccine adjuvantsF Mosca, E Tritto, A Muzzi, E Monaci, F Bagnoli, C Iavarone, D O\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'Hagan, ...Proceedings of the National Academy of Sciences 105 (30), 10501-10506, 20085342008
2-) Structure and dynamics of the pan-genome of Streptococcus pneumoniae and closely related speciesC Donati, NL Hiller, H Tettelin, A Muzzi, NJ Croucher, SV Angiuoli, ...Genome biology 11 (10), 1-19, 20103932010
3-) Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccinesJ Donnelly, D Medini, G Boccadifuoco, A Biolchi, J Ward, C Frasch, ...Proceedings of the National Academy of Sciences 107 (45), 19490-19495, 20103572010
4-) Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessmentU Vogel, MK Taha, JA Vazquez, J Findlow, H Claus, P Stefanelli, ...The Lancet infectious diseases 13 (5), 416-425, 20133612013
5-) Previously unrecognized vaccine candidates against group B meningococcus identified by DNA microarraysR Grifantini, E Bartolini, A Muzzi, M Draghi, E Frigimelica, J Berger, G Ratti, ...Nature biotechnology 20 (9), 914-921, 20022722002